Health Axsome Therapeutics to Present Five Abstracts Including New Data from the Positive SHARP Study of… Jason Junior Apr 21, 2023 <!-- Name:DistributionId Value:8812646 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4500 -->…
Health Catalyst Pharmaceuticals Announces Third-Party Abstracts on FYCOMPA® (Perampanel) to be Presented at… Jason Junior Apr 20, 2023 <!-- Name:DistributionId Value:8811786 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4577 -->…
Health Researchers Discover a New Embryonic Brain Circuit Jason Junior Apr 13, 2023 <!-- Name:DistributionId Value:1000803778 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4570 -->…
Health Global Personalized Medicine Market Is Expected to Reach $869.5 Billion by 2031: Says AMR Jason Junior Apr 6, 2023 <!-- Name:DistributionId Value:8802795 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:5557 -->…
Health Catalyst Pharmaceuticals Announces a Recent Third-Party Publication in Peer-Reviewed Journal… Jason Junior Mar 8, 2023 <!-- Name:DistributionId Value:8784399 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4577 -->…
Health TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of… Jason Junior Mar 3, 2023 <!-- Name:DistributionId Value:8781303 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…
Health Eterna Therapeutics Enters Into Option and License Agreement with Lineage Cell Therapeutics to… Jason Junior Feb 23, 2023 <!-- Name:DistributionId Value:8754151 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4500 -->…
Health Alterity Therapeutics Receives Regulatory Authorization in France and Austria to Proceed with ATH434… Jason Junior Feb 17, 2023 <!-- Name:DistributionId Value:8751371 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…
Health Neurona Therapeutics Announces FDA Clearance of Expanded Inclusion Criteria for Phase I/II Clinical… Jason Junior Feb 15, 2023 <!-- Name:DistributionId Value:8748523 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…
Health NeuroSigma Announces Strategic Digital Marketing Partnership with Data360 Jason Junior Feb 1, 2023 <!-- Name:DistributionId Value:8739167 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…